Immunotherapy Archives

Podcast 8 Sep 2023

Beyond Biotech podcast 62 – cytokine-based drugs

As September 8 is Stand Up To Cancer Day, one area of promising research lies in cytokine-based drugs, which have the potential to activate T cells against tumors. Historically, toxicity…

September 8, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 5 Sep 2023

Five recent advancements in ovarian cancer research over the past year

With around 7500 new cases reported in the U.K. alone every year, ovarian cancer may occur because of the inheritance of faulty genes like BRCA. Although the exact reason for…

September 5, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 24 Jul 2023

Sarcoma research: is a breakthrough in sight?

Among the rarest forms of cancers, sarcomas develop in the bones and connective tissues that support structures in the body like blood vessels, nerves and joints. This year, around 13,400…

July 24, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 20 Jul 2023

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

CatalYm has published preclinical data in Nature Communications that reveal the central role of Growth Differentiation Factor-15 (GDF-15) in the resistance of tumors to current immunotherapy. CatalYm said the findings…

July 20, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 4 Jul 2023

Exeliom Biosciences closes €24M financing for lead candidate

Exeliom Biosciences has completed a €24 million ($26 million) Series A to progress the clinical development of its therapeutic pipeline. This includes several clinical trials of EXL01, a novel immunotherapy…

July 4, 2023 - 3 minutesmins - By Jim Cornall

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

Our immune system serves as the body’s chief line of defense against harmful invaders. But what happens when this mighty defense mechanism turns on its own host, launching an assault…

June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter

In Depth 9 Jun 2023

Enhancing canine wellness: The promise of immunotherapy for dogs

Given that dogs are widely regarded as ‘man’s best friend’, it makes sense that we are constantly striving to find ways to improve canine health. One method that has been…

June 9, 2023 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 6 Jun 2023

Ten Swedish companies spearheading the country’s biotech scene

Known for its abundant forests, smorgasbords and not to mention the famed Europop group ABBA, Sweden has a thriving economy that largely depends on manufacturing and exports. And the country’s…

June 6, 2023 - 10 minutesmins - By David Cox

In Depth 11 May 2023

Battling food allergies: emerging immunotherapies

While for most individuals, picking a restaurant to dine at could simply be based on what they might be craving at the moment, for about one to five per cent…

May 11, 2023 - 9 minutesmins - By Roohi Mariam Peter

Best in Biotech 9 May 2023

5 cancers that immunotherapy can cure

Cancer immunotherapy dates back to 1891, when William Coley became the first person to try and harness the immune system to treat cancer. Since then, immunotherapy has become the mainstay…

May 9, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

Ever since William Coley first attempted to harness the immune system in 1891 to treat bone cancer, immunotherapy has been explored in the treatment of various different cancers - both…

May 3, 2023 - 10 minutesmins - By Willow Shah-Neville

News and Trends 24 Apr 2023

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

Researchers from Tel Aviv University in Israel have revealed details of a new approach to the treatment of ovarian cancer using RNA-based nanodrugs – demonstrating an 80% survival rate in…

April 24, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 14 Apr 2023

Researchers explain how some lung tumors avoid immunotherapy

The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy. This is the main conclusion…

April 14, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 6 Apr 2023

Cancer vaccines: 10 biotech companies that have changed the game

A kind of immunotherapy, cancer vaccines have been around since the link between human papillomavirus (HPV) and cancer was discovered in the 1980s. For the prevention of cancers - cervical,…

April 6, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 30 Mar 2023

Vaccitech announces positive topline data for chronic hepatitis study

Vaccitech plc has announced positive topline final data from the HBV002 study, a phase 1b/2a clinical trial of VTP-300 in people with chronic hepatitis B (HBV) infection. Vaccitech is a…

March 30, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 15 Mar 2023

10 immunotherapy companies making waves in 2023

Immunotherapy has been widely studied in cancer treatment research, ever since William Coley, who is regarded as the father of immunotherapy, first attempted to leverage the immune system for oncological…

March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 14 Mar 2023

How the microbiome can predict cancer immunotherapy success

A new study shows antibiotic treatment prior to CAR-T cell therapy is connected to unfavorable treatment outcomes. An international team headed by Eran Elinav of the Cancer & Microbiome Division…

March 14, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 24 Feb 2023

AELIX announces ‘important step towards HIV eradication’

AELIX Therapeutics S.L., a clinical-stage biotechnology company specializing in the discovery and development of immunotherapies for HIV infection, has announced positive topline results from its AELIX-003 trial. The study evaluated…

February 24, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 16 Feb 2023

Cytovation melanoma study under way

Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane immunotherapy, announces that the first patient has been dosed in its…

February 16, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 9 Feb 2023

TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials

TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million ($23.8 million) round. This follows on from the first close of €10 million in June…

February 9, 2023 - 2 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering